With An Investment Of 580 Million Yuan, The NMN Industrialization Project Was Officially Launched


ANHUI GSH BIO-TECHNOLOGY CO.,LTD. was established in 2013. It is a production-oriented enterprise integrating biological scientific research and production, focusing on the enzyme catalysis technology in the field of synthetic biology, and specializing in the development of biological raw materials.

Products are widely used in food, cosmetics, health care products, medicine and other fields. We have been committed to providing customers with better and more environmentally friendly products and services. There are two production bases in Anqing, Anhui and Dunhua, Jilin.

▲Anqing production base

▲Jilin production base

With the continuous expansion of the global market, and customers’ requirements for product customization and quality are getting higher and higher, as a powerful production enterprise, in order to respond to the growing customer needs in a timely manner, Gut Xinsheng started in Jilin at the beginning of this year. Dunhua once again invested in the construction of an NMN production base to meet the needs of global customers.

▲Aerial view of production base

The new Dunhua factory is also the third factory of Gute Neobio, located in Dunhua, Jilin, the “West Gate” of Yanbian Prefecture.

The investment scale of the new factory is 580 million yuan. The factory covers an area of about 62,000 square meters and a construction area of 33,000 square meters. It mainly builds standard fermentation workshops, reaction workshops, purification workshops, crystallization workshops, as well as raw material and product warehouses. It is estimated that during the “14th Five-Year Plan” period, the annual output of NMN will reach more than 1,000 tons.

The establishment of Dunhua’s new factory will also attract more outstanding talents and a huge resource supply chain, comprehensively improve product quality standards and service standards, enhance product competitiveness and respond quickly to customer needs, while enhancing the company’s presence in the global supply chain. Flexibility to accelerate the pace of expanding the global market.

NMN is a naturally occurring substance in the human body, and it also exists in many foods. It is purely natural and harmless. Studies have shown that NMN supplementation does not affect the activities of various enzymes in the supplementary synthesis pathway. Long-term oral administration of NMN can effectively increase the NAD+ level in age-related tissues without adverse reactions and has good tolerance. The effect of NMN highlights NAD+ Preventive and therapeutic potential of intermediates as effective antiaging interventions in humans.